WDHD1 and non-small cell lung carcinoma: knocked down the expression of WDHD1, tested the radiotherapy sensitivity of non‐small cell lung cancer cells (NSCLC) by clonal formation assay, flow cytometry, comet assay, and immunofluorescence and verified it in a vivo xenograft tumor model.